Literature DB >> 8011071

Covalent structure of botulinum neurotoxin type A: location of sulfhydryl groups, and disulfide bridges and identification of C-termini of light and heavy chains.

K G Krieglstein1, B R DasGupta, A H Henschen.   

Abstract

Botulinum neurotoxin Type A is synthesized by Clostridium botulinum as a approximately 150 kD single chain polypeptide. The posttranslational processing of the 1296 amino acid residue long gene product involves removal of the initiating methionine, formation of disulfide bridges, and limited proteolysis (nicking) by the bacterial protease(s). The mature dichain neurotoxin is made of a approximately 50-kD light chain and a approximately 100-kD heavy chain connected by a disulfide bridge. DNA derived amino acid sequence predicted a total of 9 Cys residues (Binz et al., 1990, J. Biol. Chem. 265, 9153-9158; Thompson et al., 1990, Eur. J. Biochem. 189, 73-81). Treatment of the dichain neurotoxin, dissolved in 6 M guanidine. HCl, with 4-vinylpyridine converted 5 Cys residues into S-pyridylethyl cysteine residues; but alkylation after mercaptolysis converted all 9 Cys residues in the S-pyridylethylated form. After confirming the predicted number of Cys residues by amino acid analysis, the positions of the 5 Cys residues carrying sulfhydryl groups and the 4 involved in disulfide bridges were determined by comparing the elution patterns in reversed-phase HPLC of the cyanogen bromide mixtures of the exclusively alkylated and the mercaptolyzed-alkylated neurotoxin. The chromatographically isolated components were identified by N-terminal amino acid sequence analysis. The HPLC patterns showed characteristic differences. The Cys residues predicted in positions 133, 164, 790, 966, and 1059 were found in the sulfhydryl form; Cys 429 and 453 were found disulfide-bridge connecting the light and heavy chains, and Cys 1234 and 1279 were found in an intrachain disulfide-bridge near the C-terminus in the heavy chain.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8011071     DOI: 10.1007/bf01891992

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  25 in total

1.  Nucleotide sequence of the gene encoding Clostridium botulinum neurotoxin type D.

Authors:  T Binz; H Kurazono; M R Popoff; M W Eklund; G Sakaguchi; S Kozaki; K Krieglstein; A Henschen; D M Gill; H Niemann
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

Review 2.  Structure and biological activity of botulinum neurotoxin.

Authors:  B R DasGupta
Journal:  J Physiol (Paris)       Date:  1990

3.  Arrangement of disulfide bridges and positions of sulfhydryl groups in tetanus toxin.

Authors:  K Krieglstein; A Henschen; U Weller; E Habermann
Journal:  Eur J Biochem       Date:  1990-02-22

4.  The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding gene.

Authors:  D E Thompson; J K Brehm; J D Oultram; T J Swinfield; C C Shone; T Atkinson; J Melling; N P Minton
Journal:  Eur J Biochem       Date:  1990-04-20

5.  A common subunit structure in Clostridium botulinum type A, B and E toxins.

Authors:  B R DasGupta; H Sugiyama
Journal:  Biochem Biophys Res Commun       Date:  1972-07-11       Impact factor: 3.575

6.  Separation, purification, partial characterization and comparison of the heavy and light chains of botulinum neurotoxin types A, B, and E.

Authors:  V Sathyamoorthy; B R DasGupta
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

7.  Minimal essential domains specifying toxicity of the light chains of tetanus toxin and botulinum neurotoxin type A.

Authors:  H Kurazono; S Mochida; T Binz; U Eisel; M Quanz; O Grebenstein; K Wernars; B Poulain; L Tauc; H Niemann
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

8.  C. botulinum neurotoxin types A and E: isolated light chain breaks down into two fragments. Comparison of their amino acid sequences with tetanus neurotoxin.

Authors:  B R DasGupta; J Foley
Journal:  Biochimie       Date:  1989 Nov-Dec       Impact factor: 4.079

9.  Nicking of single chain Clostridium botulinum type A neurotoxin by an endogenous protease.

Authors:  M L Dekleva; B R DasGupta
Journal:  Biochem Biophys Res Commun       Date:  1989-07-31       Impact factor: 3.575

10.  Molecular cloning of the Clostridium botulinum structural gene encoding the type B neurotoxin and determination of its entire nucleotide sequence.

Authors:  S M Whelan; M J Elmore; N J Bodsworth; J K Brehm; T Atkinson; N P Minton
Journal:  Appl Environ Microbiol       Date:  1992-08       Impact factor: 4.792

View more
  16 in total

1.  Epitope mapping of neutralizing botulinum neurotoxin A antibodies by phage display.

Authors:  B P Mullaney; M G Pallavicini; J D Marks
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  In Vivo Toxicity and Immunological Characterization of Detoxified Recombinant Botulinum Neurotoxin Type A.

Authors:  Easwaran Ravichandran; Pavithra Janardhanan; Kruti Patel; Stephen Riding; Shuowei Cai; Bal Ram Singh
Journal:  Pharm Res       Date:  2015-11-03       Impact factor: 4.200

3.  The role of exoproteases in governing intraneuronal metabolism of botulinum toxin.

Authors:  Lance L Simpson; Andrew B Maksymowych; Hirokazu Kouguchi; Garrett Dubois; Roop S Bora; Suresh Joshi
Journal:  Protein J       Date:  2005-04       Impact factor: 2.371

Review 4.  Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting.

Authors:  B R Singh
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 5.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

6.  Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species.

Authors:  M Z Atassi; B Z Dolimbek; M Hayakari; J L Middlebrook; B Whitney; M Oshima
Journal:  J Protein Chem       Date:  1996-10

7.  Processing of tetanus and botulinum A neurotoxins in isolated chromaffin cells.

Authors:  E Erdal; F Bartels; T Binscheck; G Erdmann; J Frevert; A Kistner; U Weller; J Wever; H Bigalke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

8.  The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active site.

Authors:  Rahman M Mizanur; Verna Frasca; Subramanyam Swaminathan; Sina Bavari; Robert Webb; Leonard A Smith; S Ashraf Ahmed
Journal:  J Biol Chem       Date:  2013-06-18       Impact factor: 5.157

9.  Lipid and cationic polymer based transduction of botulinum holotoxin, or toxin protease alone, extends the target cell range and improves the efficiency of intoxication.

Authors:  Chueh-Ling Kuo; George Oyler; Charles B Shoemaker
Journal:  Toxicon       Date:  2009-10-21       Impact factor: 3.033

10.  Recombinant derivatives of botulinum neurotoxin A engineered for trafficking studies and neuronal delivery.

Authors:  Philip A Band; Steven Blais; Thomas A Neubert; Timothy J Cardozo; Konstantin Ichtchenko
Journal:  Protein Expr Purif       Date:  2010-01-04       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.